Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 28, 2023

Study Completion Date

October 28, 2023

Conditions
ScarHypertrophic Scar
Interventions
DRUG

Botulinum Toxin

We will be comparing botulinum toxin following the biopsies to placebo injection. We will then compare photos of each biopsy site at set intervals following the procedure.

DRUG

Normal saline

Normal saline will serve as the placebo control on the contralateral side of the back.

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER